Journal of Translational Medicine

Table 1 Univariate and multivariate proportional hazards analyses linking SULF2 expression to prognosis in HM cohort

From: SULFs in human neoplasia: implication as progression and prognosis factors

HM cohort (OS)
	Pronostic variable	Proportional hazard ratio	P-value
Univariate Cox analysis	SULF2 ISS	4.08 1.73	*0.007* *0.001*
Multivariate Cox analysis	SULF2 ISS	3.65 1.70	*0.028* *0.001*
Univariate Cox analysis	SULF2 b2M Alb	4.08 1.10 1.60	*0.007* *0.0001* *0.04*
Multivariate Cox analysis	SULF2 b2M Alb	3.49 1.10 1.35	*0.03* *0.0001* *0.24*
Univariate Cox analysis	SULF2 HRS	4.08 2.30	*0.007* *0.002*
Multivariate Cox analysis	SULF2 HRS	4.11 2.31	*0.01* *0.002*
Univariate Cox analysis	SULF2 MS group	4.08 2.14	*0.007* *0.001*
Multivariate Cox analysis	SULF2 MS group	3.84 1.97	*0.023* *0.028*
Univariate Cox analysis	SULF2 IFM score	4.08 3.09	*0.007* *0.0001*
Multivariate Cox analysis	SULF2 IFM score	4.29 3.22	*0.014* *0.0001*
Univariate Cox analysis	SULF2 GPI	4.08 2.21	*0.007* *0.0001*
Multivariate Cox analysis	SULF2 GPI	4.47 2.25	*0.011* *0.0001*
Univariate Cox analysis	SULF2 MYEOV	4.08 3.16	*0.007* *0.05*
Multivariate Cox analysis	SULF2 MYEOV	3.71 2.76	*0.026* *0.08*
Univariate Cox analysis	SULF2 CD200	4.08 2.05	*0.007* *0.03*
Multivariate Cox analysis	SULF2 CD200	3.86 1.03	*0.02* *0.05*

Univariate analyses were done to screen for prognostic variables linked to SULF2 expression using Cox proportional hazards regression. The Cox model was also used for multivariate analysis to identify the most significant variables related to survival (OS): ISS (international staging system), b2M (beta-2 microglobulin), Alb (Albumin), HRS (High Risk Score), MS group (MMSET group), IFM score (IFM score), GPI (Growth Proliferation Index), MYEOV and CD200. P-values are in bold and italic when a significant result was obtained (p < 0.05).

Back to article page

ISSN: 1479-5876

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com